Immuneel eyes West Asia, Asia-Pacific expansion for cancer therapy after ₹100 crore funding Vimal Sharma 6 hours ago The company says its lower-cost treatment could help it compete in emerging markets across West Asia and Asia-Pacific. Share this: Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X
